HBK Investments L P Trims Stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ)

HBK Investments L P reduced its position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 20.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 115,256 shares of the company’s stock after selling 29,421 shares during the period. HBK Investments L P’s holdings in BlackRock Health Sciences Term Trust were worth $1,826,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the company. Sessa Capital IM L.P. lifted its holdings in shares of BlackRock Health Sciences Term Trust by 27.1% during the 2nd quarter. Sessa Capital IM L.P. now owns 1,853,022 shares of the company’s stock worth $28,462,000 after acquiring an additional 395,288 shares during the last quarter. Almitas Capital LLC lifted its holdings in shares of BlackRock Health Sciences Term Trust by 89.3% during the 2nd quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock worth $27,063,000 after acquiring an additional 831,025 shares during the last quarter. Penserra Capital Management LLC bought a new stake in shares of BlackRock Health Sciences Term Trust during the 3rd quarter worth $15,390,000. Allspring Global Investments Holdings LLC lifted its holdings in shares of BlackRock Health Sciences Term Trust by 66.3% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 399,964 shares of the company’s stock worth $6,143,000 after acquiring an additional 159,401 shares during the last quarter. Finally, Sanctuary Advisors LLC bought a new stake in shares of BlackRock Health Sciences Term Trust during the 2nd quarter worth $3,179,000.

BlackRock Health Sciences Term Trust Stock Up 1.0 %

NYSE BMEZ opened at 15.56 on Friday. BlackRock Health Sciences Term Trust has a 52-week low of 13.72 and a 52-week high of 16.59. The company has a fifty day moving average of 15.66 and a 200-day moving average of 15.59.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be paid a $0.1769 dividend. This represents a $2.12 annualized dividend and a yield of 13.64%. The ex-dividend date of this dividend is Friday, November 15th.

Insiders Place Their Bets

In other news, major shareholder Saba Capital Management, L.P. acquired 15,455 shares of the stock in a transaction dated Thursday, September 19th. The stock was purchased at an average cost of 16.14 per share, with a total value of 249,443.70. Following the completion of the purchase, the insider now owns 20,601,568 shares in the company, valued at approximately 332,509,307.52. The trade was a 0.08 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders acquired 99,630 shares of company stock valued at $1,585,113 over the last three months.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.